2001
DOI: 10.1016/s0093-691x(00)00447-7
|View full text |Cite
|
Sign up to set email alerts
|

Effects of hormonal treatments on reproductive performance and embryo production

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

4
58
0
11

Year Published

2005
2005
2018
2018

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 133 publications
(76 citation statements)
references
References 30 publications
4
58
0
11
Order By: Relevance
“…During early luteal phase, inadequate or low progesterone levels generally cause to strike against embryonic development (Nephew et al 1991). For this reason, progesterone from corpus luteum is needed for embryonic implantation and development in uterus (Thatcher et al 2001) or exogenous progesterone applications may be needed to continue these vital processes for embryo (Davies and Beck 1992;Nephew et al 1994;Rostami et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…During early luteal phase, inadequate or low progesterone levels generally cause to strike against embryonic development (Nephew et al 1991). For this reason, progesterone from corpus luteum is needed for embryonic implantation and development in uterus (Thatcher et al 2001) or exogenous progesterone applications may be needed to continue these vital processes for embryo (Davies and Beck 1992;Nephew et al 1994;Rostami et al 2017).…”
Section: Introductionmentioning
confidence: 99%
“…É possível que o rbST melhore a maturação nuclear e citoplasmática dos oócitos (Bevers et al, 1997;Izadyar et al, 1997, Bevers &Izadyar, 2002. Além disso, o tratamento das doadoras de embriões com rbST reduz a proporção de oócitos não-fecundados e aumenta o número de embriões transferíveis (Thatcher et al, 2001).…”
Section: Resultsunclassified
“…However, ovarian responsiveness to gonadotropins remains highly variable among individuals, and such unpredictability has become a major limiting factor for the development of embryo transfer (Mapletoft et al, 2002;Mapletoft and Hasler, 2005). Although several sources of this variability have been identified, including follicle stage, age, parity, and nutritional and gonadotropin reparation (Kafi and McGowan, 1997;Thatcher et al, 2001;Bó et al, 2002;Mossa et al, 2007;Malhi et al, 2008), no significant improvement in the superovulatory response has been observed since the early 1990s (Cory et al, 2013). The candidate gene approach has been widely used in genetic association and biomarker studies in animals and humans (Tabor et al, 2002).…”
Section: Introductionmentioning
confidence: 99%